Krystal Biotech Cash Flow Statement (2016-2026) | KRYS

Cash Flow Statement Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-16.36M-15.59M-21.81M-49.97M-28.11M-29.85M-32.05M-45.30M-33.21M80.75M8.69M0.93M15.57M27.18M45.51M35.73M38.38M79.36M51.40M55.93M
Depreciation and Depletion (Quarter)
0.47M0.47M0.45M0.46M0.49M0.67M1.04M1.10M1.20M1.20M1.50M1.43M1.80M1.30M1.40M1.40M1.30M1.40M1.54M1.52M
Share-based Compensation (Quarter)
4.20M3.67M5.14M6.43M8.19M9.06M9.55M10.44M11.33M8.31M9.85M9.30M13.16M13.32M13.36M13.48M14.12M13.15M13.76M13.61M
Deferred Taxes (Quarter)
-1.83M
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)
1.49M1.39M-1.41M-0.01M1.58M0.81M1.58M1.50M-3.89M2.86M2.29M-5.15M1.80M12.06M-8.31M-3.76M0.53M
Non-cash Items (Quarter)
Cash from Operations (Quarter)
-10.13M-7.25M-20.90M-15.49M-43.06M-19.69M-22.33M-26.16M-34.19M-21.23M-7.23M15.89M-4.17M58.86M52.84M30.97M52.73M39.66M77.51M80.38M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.22M0.22M0.23M0.23M0.18M0.19M0.19M0.19M0.22M0.19M0.21M0.20M0.20M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)
0.67M0.78M0.78M1.01M0.98M0.97M1.09M0.70M1.04M0.83M1.50M1.43M1.80M1.30M1.40M1.40M1.30M1.40M1.54M1.52M
Change in Working Capital
Change in Receivables (Quarter)
9.32M32.72M4.43M56.77M-5.94M7.45M-1.49M8.18M17.92M-2.49M-0.06M
Change in Inventory (Quarter)
0.91M3.08M0.49M2.24M-0.53M3.68M6.52M1.40M-0.88M4.71M1.06M0.24M
Change in Account Payables (Quarter)
-0.97M0.46M0.94M-0.55M0.58M-0.34M-0.94M0.11M0.37M-0.36M-0.22M0.73M0.78M0.09M-0.59M0.91M4.12M-4.02M-0.18M1.02M
Change in Accured Expenses (Quarter)
2.52M3.93M-4.02M2.01M0.46M0.54M2.16M-3.46M1.80M2.54M3.68M-5.16M1.13M1.94M7.48M3.69M-1.29M5.92M5.79M-6.31M
Change in Taxes (Quarter)
0.97M-0.46M2.29M-3.37M
Other Working Capital Changes (Quarter)
-1.38M0.33M0.58M-0.82M-0.03M0.62M0.84M0.00M0.05M0.41M1.15M-0.24M0.33M0.67M-0.11M3.43M-2.06M0.35M0.56M0.14M
Investing Activities
Capital Expenditures (Quarter)
3.85M20.99M-12.09M14.51M19.20M-18.40M-0.38M11.87M-0.87M0.10M-2.50M8.46M-6.07M1.05M0.80M1.40M6.71M-7.49M2.44M7.15M
Sales of Property, Plant and Equipment (Quarter)
0.43M
Change in Acquisitions & Divestments (Quarter)
1.23M8.07M21.00M24.04M62.79M66.77M104.08M154.52M161.23M112.87M74.59M63.62M95.18M79.25M60.49M88.81M105.28M95.79M85.76M103.60M
Cash from Investing Activities (Quarter)
-62.32M-37.17M-126.54M-55.91M-38.22M-14.74M-5.21M3.56M-15.96M105.19M-10.16M-25.98M-19.35M-34.33M-83.78M-54.77M-10.53M-4.29M11.16M-63.58M
Financing Activities
Cash from Financing Activities (Quarter)
-0.20M1.51M202.07M-0.54M30.70M2.12M3.07M1.47M185.27M13.39M2.62M10.58M10.64M3.37M2.43M-12.47M1.80M3.71M15.67M-10.46M
Additional items
Exchange Rate Effect (Quarter)
-0.04M-0.04M0.01M0.01M-0.14M0.19M-0.34M0.29M-0.59M0.17M1.06M-0.31M-0.64M-1.33M
Change in Cash (Quarter)
-72.64M-42.91M54.63M-71.94M-50.58M-32.31M-24.51M-21.16M135.13M97.37M-14.91M0.68M-13.22M28.18M-29.10M-36.09M45.06M38.77M103.70M5.01M
Free Cash Flow (Quarter)
-13.98M-28.25M-8.81M-30.00M-62.26M-1.29M-21.95M-38.02M-33.32M-21.33M-4.73M7.43M1.90M57.81M52.04M29.57M46.02M47.14M75.06M73.23M
Net Cash Flow (Quarter)
-72.64M-42.91M54.63M-71.94M-50.58M-32.31M-24.47M-21.12M135.12M97.35M-14.77M0.49M-12.88M27.89M-28.51M-36.27M44.00M39.08M104.34M6.34M